Litigation Details for ASTRAZENECA AB v. PERRIGO COMPANY PLC (D.N.J. 2015)
✉ Email this page to a colleague
ASTRAZENECA AB v. PERRIGO COMPANY PLC (D.N.J. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-02-03 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-06-09 |
| Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 6,369,085; 6,428,810; 7,411,070 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTRAZENECA AB v. PERRIGO COMPANY PLC
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for ASTRAZENECA AB v. PERRIGO COMPANY PLC (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-02-03 | 1 | The Patents-in-Suit 16. United States Patent No. 6,369,085 (“the ’085 patent”), entitled… sell products covered by United States Patent Nos. 6,369,085 and 7,411,070. 6. On information… This is a civil action for patent infringement arising under the patent laws of the United States, …been and still is the owner of the ’085 patent. The ’085 patent will expire on May 25, 2018, and pediatric… 18. United States Patent No. 7,411,070 (“the ’070 patent”), entitled “Form of S- omeprazole | External link to document | |
| 2015-04-22 | 22 | mg and The Patent-in-Suit 22. Plaintiffs admit United States Patent No. 6,369,085 (“the ’085… Plaintiffs admit United States Patent No. 7,411,070 (“the ’070 patent”), entitled “Form of S-Omeprazole…085 patent”), entitled “Form of S-Omeprazole,” was duly and legally issued by the United States Patent…certification with respect to the ’085 and ’070 patents. Plaintiffs deny the remaining allegations of … (Declaration of Non-Infringement of ’085 Patent) 34. Plaintiffs repeat and reassert | External link to document | |
| 2015-02-08 | 4 | TRADEMARK NO. OR TRADEMARK 1 US 6,369,085 B1 4/9/2002 … PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK…Pleading PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK… ____ Trademarks or X Patents. ( ____ the patent action involves 35 U.S.C. § 292.) DOCKET… AO120 Patent/Trademark Form filed. (jjc) (Entered: 02/09/2015) 9 February 2015 PACER Document | External link to document | |
| 2015-12-08 | 53 | eight patents listed for NEXIUM 24HR® in the FDA’s Orange Book: U.S. Patent No. 6,369,085 (the “‘…“‘085 patent”) and U.S. Patent No. 7,411,070 (the “‘070 patent”). AstraZeneca did not assert any claims…infringement and invalidity as to U.S. Patent No. 6,428,810 (the “‘810 patent”). [Docket Entry No. 41]. Plaintiffs…Perrigo on the other patents listed in the Orange Book, including the ‘810 patent even though Perrigo…with infringement of the ‘810 patent, then discovery regarding this patent and a Markman hearing will | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
